The Institute of Medicine National Strategy for Prevention and Control of Hepatitis B and Hepatitis C: Implications for STD Prevention Programs

Background: In December 2008-August 2009, the Institute of Medicine (IOM) convened an expert panel to review hepatitis B virus (HBV) and hepatitis C virus (HCV) prevention in the United States. The review was sponsored by CDC and other federal and non-governmental partners

Objectives: The expert panel was charged to examine three issues: strategies for preventing HBV and HCV infections, reducing morbidity and mortality from chronic HBV and HCV infection, and the data needed to guide and evaluate prevention services.

Methods: The IOM panel was comprised of 15 experts in public health, clinical care, and other fields. The panel examined data collected from publications, governmental documents, and testimonies. From this information, the panel prepared a draft which was reviewed by a second panel of experts. The IOM findings were released in January 2010.

Results: The IOM panel identified chronic viral hepatitis as a serious health problem in the United States. Awareness of chronic viral hepatitis was deemed inadequate resulting in missed opportunities for prevention and inadequate investments in prevention. The IOM issued 22 recommendations in four areas. 1) Increase support for acute and chronic disease surveillance and related services ( e.g., partner notification)2) Growth of community outreach and education programs for at-risk populations and their providers; 3) Resources to implement vaccine-based strategies and eliminate HBV transmission; 4) Provide essential services for all persons living with chronic viral hepatitis (i.e., education, harm reduction, screening, social support, and medical management). IOM recommended integration of viral hepatitis prevention services in STD clinics and other settings serving high risk populations.

Conclusions: The IOM recommendations present priorities for viral hepatitis prevention and care in the United States which have implications for STD prevention programs. 

Implications for Programs, Policy, and/or Research: Report priorities can guide efforts to develop feasible strategies for the integration of viral hepatitis and STD prevention services.